386 filings
Page 2 of 20
D
ecg7m4mnyt9xs9gt98
17 Aug 23
$85.00 mm in equity, sold $85.00 mm, 47 investors
3:52pm
8-K
etjaxe9rup
2 Aug 23
PacBio Announces Second Quarter 2023 Financial Results
4:10pm
8-K
7zqnu
30 Jun 23
Entry into a Material Definitive Agreement
4:25pm
8-K
oyk8w3gpbojrinoeyj
23 Jun 23
PacBio Announces a Private Convertible Exchange Transaction of $441 Million Principal Amount of 1.375% Convertible Senior Notes due 2030
7:56pm
8-K
iv8rrzur3o6uinb
26 May 23
Submission of Matters to a Vote of Security Holders
4:13pm
SD
n6w1jwibffkt5wrhq
24 May 23
Conflict minerals disclosure
12:00am
8-K
vy0qbgi0pz72
2 May 23
PacBio Announces Record Revenue in First Quarter 2023
4:03pm
ARS
aeros8s
13 Apr 23
Annual report to shareholders
4:07pm
DEFA14A
cv4j yanrtcvx5xt2o8p
13 Apr 23
Additional proxy soliciting materials
4:06pm
PRE 14A
2d9k 4qjo437x
27 Mar 23
Preliminary proxy
5:12pm
S-8
u8467k x37drzu
28 Feb 23
Registration of securities for employees
4:46pm
8-K
t8vv9av7ild6krjku
16 Feb 23
PacBio Announces Fourth Quarter and Fiscal Year 2022 Financial Results
4:07pm
8-K
9drxgzc
27 Jan 23
Pacific Biosciences of California, Inc. Announces Pricing of Upsized Public Offering of Common Stock
4:05pm
424B5
hs2u 4uakcslb
25 Jan 23
Prospectus supplement for primary offering
6:02am
424B5
gxpuwh
24 Jan 23
Prospectus supplement for primary offering
5:12pm
8-K
nn2aqn0
24 Jan 23
Pacific Biosciences of California, Inc. Announces Proposed Public Offering of Common Stock
4:43pm